Construction of Anti-CD20 Single-Chain Antibody-CD28-CD137-TCRζ Recombinant Genetic Modified T Cells and its Treatment Effect on B Cell Lymphoma (Q42533033)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 July 2015

Language	Label	Description	Also known as
English	Construction of Anti-CD20 Single-Chain Antibody-CD28-CD137-TCRζ Recombinant Genetic Modified T Cells and its Treatment Effect on B Cell Lymphoma	scientific article published on 21 July 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

Construction of Anti-CD20 Single-Chain Antibody-CD28-CD137-TCRζ Recombinant Genetic Modified T Cells and its Treatment Effect on B Cell Lymphoma (English)

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

author name string

Fei Chen

1

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

Chuming Fan

2

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

Xuezhong Gu

3

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

Haixi Zhang

4

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

Qian Liu

5

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

Xiaoli Gao

6

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

Jie Lu

7

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

Baoli He

8

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

Xun Lai

9

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

publication date

21 July 2015

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Medical Science Monitor

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

21

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

2110-2115

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

The CD28-B7 Family in Anti-Tumor Immunity: Emerging Concepts in Cancer Immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

28 May 2018

Novel treatment strategies for cancer and their tumor-targeting approaches using antibodies against tumor-associated antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

28 May 2018

Clinical application of adoptive T cell therapy in solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

28 May 2018

Targeting CD28 to prevent transplant rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

28 May 2018

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

28 May 2018

Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

28 May 2018

The inside out of lentiviral vectors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

28 May 2018

Therapeutic effect of lenalidomide in a novel xenograft mouse model of human blastic NK cell lymphoma/blastic plasmacytoid dendritic cell neoplasm.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

28 May 2018

Current standards and future strategies in immunochemotherapy of non-Hodgkin's lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

28 May 2018

Active and passive immunotherapy for lymphoma: proving principles and improving results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

28 May 2018

Rituximab plus short-duration chemotherapy followed by Yttrium-90 Ibritumomab tiuxetan as first-line treatment for patients with follicular non-Hodgkin lymphoma: a phase II trial of the Sarah Cannon Oncology Research Consortium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

28 May 2018

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

28 May 2018

Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

28 May 2018

Targeting tumours with genetically enhanced T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

28 May 2018

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

28 May 2018

Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

16 August 2018

CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

16 August 2018

Co-stimulatory molecules in and beyond co-stimulation - tipping the balance in atherosclerosis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

3 November 2018

Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4537073

3 November 2018

Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a

1 reference

https://pubmed.ncbi.nlm.nih.gov/26195067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26195067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/26195067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphoma classification proposal: clarification

1 reference

https://pubmed.ncbi.nlm.nih.gov/26195067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic modification of T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/26195067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/26195067

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.12659/MSM.893791

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42533033&oldid=2156595722"